
51 - 200 employees
Founded 2004
🧬 Biotechnology
💊 Pharmaceuticals
💰 $75M Post IPO equity on 2024-02
Biotechnology • Pharmaceuticals
Liquidia is a biopharmaceutical company focused on developing inhaled therapies for rare cardiopulmonary diseases, particularly pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company leverages its proprietary PRINT® particle engineering technology to create proprietary formulations and delivery methods aimed at improving efficacy, tolerability, and convenience of inhaled medicines; its pipeline includes inhaled treprostinil (commercial product) and clinical-stage candidates such as L606. Liquidia emphasizes patient support, clinical development, and advancing therapies for improved respiratory outcomes.
🔥 2 hours ago
Improve your chances of getting an interview by checking your resume score before you apply.

51 - 200 employees
Founded 2004
🧬 Biotechnology
💊 Pharmaceuticals
💰 $75M Post IPO equity on 2024-02
Biotechnology • Pharmaceuticals
Liquidia is a biopharmaceutical company focused on developing inhaled therapies for rare cardiopulmonary diseases, particularly pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD). The company leverages its proprietary PRINT® particle engineering technology to create proprietary formulations and delivery methods aimed at improving efficacy, tolerability, and convenience of inhaled medicines; its pipeline includes inhaled treprostinil (commercial product) and clinical-stage candidates such as L606. Liquidia emphasizes patient support, clinical development, and advancing therapies for improved respiratory outcomes.
• *Strategic Medical Affairs Leadership* • - Lead development and execution of the European Medical Affairs strategy aligned with global objectives and regional unmet medical needs in PAH and PH-ILD. • - Establish Liquidia as a scientific leader within the European pulmonary vascular community through high-impact scientific exchange and strategic external engagement. • - Develop regional and national KOL engagement plans targeting pulmonary hypertension centers of excellence, multidisciplinary care teams, investigators, and scientific societies. • - Support EU launch readiness activities, including L606 scientific platform development, stakeholder mapping, advisory engagement, and medical education initiatives. • - Maintain and develop materials related to advanced knowledge of emerging science, treatment paradigms, competitive intelligence, and evolving clinical practice within pulmonary vascular disease. • *Scientific Engagement* • - Build and maintain strong scientific relationships with KOLs, investigators, site networks, and patient advocacy groups across Europe. • - Represent Medical Affairs at international, national, and regional scientific congresses and ensure coordinated scientific engagement and effective post-congress follow-up activities. • - Identify opportunities to influence scientific dialogue, evidence-generation priorities, and treatment paradigms in PAH and PH-ILD. • - Support scientific exchange related to clinical development programs, unmet medical needs, and real-world treatment challenges.
• - Advanced scientific degree (PharmD, PhD, MD) required. • - More than 15 years of Medical Affairs experience in biotech or pharmaceutical industries, including significant field-based experience as an MSL. • - Strong therapeutic expertise in PAH, PH-ILD, pulmonary hypertension, interstitial lung disease, or related cardiopulmonary conditions preferred. • - Deep understanding of clinical research processes, including best practices and support models for investigator-initiated research (IIR). • - Excellent communication, interpersonal, and coaching skills with a demonstrated ability to motivate and develop field personnel. • - Highly organized, with strong analytical ability and comfort working in a fast-paced, cross-functional environment. • - Ability to travel 60% across Europe.
• Liquidia offers a competitive compensation package as well as a comprehensive benefits package that includes Medical, Dental, Vision, STD, LTD, 401(k) Savings Retirement Plan, ESPP, Unlimited Paid Time Off and more!
Apply Now🔥 3 hours ago
Lead global regulatory strategy and execution for gene therapy programs from research through commercialization. Collaborate with internal teams and global regulatory agencies on submissions and guidelines.
🇺🇸 United States – Remote
💵 $160k - $220k / year
💰 $150M Series C - Atsena Therapeutics on 2025-04
⏰ Full Time
🟠 Senior
👨⚕️ Medical Director
🔥 3 hours ago
Sr. Director, Medical Writing leading the preparation of regulatory documents for SAB’s biologic product pipeline. Requires deep expertise in biologics writing for FDA and EMA submissions.
🔥 3 hours ago
Lead the strategic development and execution of the field medical organization for cell therapy. Shape field medical strategy and build relationships with KOLs and clinical investigators.
🔥 4 hours ago
Senior Account Executive selling AI-powered remote patient monitoring systems to physician practices. Owning the full sales cycle and building relationships with medical professionals.
🔥 4 hours ago
Senior Account Executive selling AI-powered remote patient monitoring solutions for physician practices. Managing sales cycle from prospecting through negotiations and building lasting relationships.